The interaction between PD-1 and PD-L1 induces T cell dysfunction, weakening the anti-tumor immune system as part of the immune checkpoint axis, thereby allowing tumor cells to evade the host’s anti-tumor immune response. The gene discussed is CD274; the disease is neoplasm.